 | • レポートコード：D0GIR-01121 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオシミラー/生物学的製剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオシミラー/生物学的製剤の種類別市場規模（ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、その他）、用途別市場規模（血液疾患、腫瘍疾患、慢性・自己免疫疾患、成長ホルモン欠乏症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis (Sandoz)、Biogen idec、LG Life Sciences、Synthon Pharmaceuticals、Merck Serono (Merck)、Teva Pharmaceutical Industries、Hospira、Celltrion Biocon、Genentech (Roche) ・地域別グローバル市場分析 2015年-2020年 ・バイオシミラー/生物学的製剤の北米市場（アメリカ、カナダ、メキシコ） ・バイオシミラー/生物学的製剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオシミラー/生物学的製剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオシミラー/生物学的製剤の南米市場（ブラジル、アルゼンチン） ・バイオシミラー/生物学的製剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、その他 ・用途別分析：血液疾患、腫瘍疾患、慢性・自己免疫疾患、成長ホルモン欠乏症、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Biosimilars/follow-on-biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 10730 million by 2025, from USD 9560.2 million in 2019.
The Biosimilars/follow-on-biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biosimilars/follow-on-biologics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biosimilars/follow-on-biologics market has been segmented into:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
By Application, Biosimilars/follow-on-biologics has been segmented into:
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilars/follow-on-biologics market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilars/follow-on-biologics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilars/follow-on-biologics market.
The report offers in-depth assessment of the growth and other aspects of the Biosimilars/follow-on-biologics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biosimilars/follow-on-biologics Market Share Analysis
Biosimilars/follow-on-biologics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biosimilars/follow-on-biologics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilars/follow-on-biologics sales, revenue and market share for each player covered in this report.
The major players covered in Biosimilars/follow-on-biologics are:
Novartis (Sandoz)
Biogen idec
LG Life Sciences
Synthon Pharmaceuticals
Merck Serono (Merck)
Teva Pharmaceutical Industries
Hospira
Celltrion Biocon
Genentech (Roche)
Table of Contents
1 Biosimilars/follow-on-biologics Market Overview
1.1 Product Overview and Scope of Biosimilars/follow-on-biologics
1.2 Classification of Biosimilars/follow-on-biologics by Type
1.2.1 Global Biosimilars/follow-on-biologics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Type in 2019
1.2.3 Human growth hormone
1.2.4 Erythropoietin
1.2.5 Monoclonal antibodies
1.2.6 Insulin
1.2.7 Interferon
1.2.8 Granulocyte-Colony Stimulating Factor
1.2.9 Others
1.3 Global Biosimilars/follow-on-biologics Market by Application
1.3.1 Overview: Global Biosimilars/follow-on-biologics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Blood disorders
1.3.3 Oncology diseases
1.3.4 Chronic and autoimmune diseases
1.3.5 Growth hormone deficiencies
1.3.6 Others
1.4 Global Biosimilars/follow-on-biologics Market by Regions
1.4.1 Global Biosimilars/follow-on-biologics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biosimilars/follow-on-biologics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biosimilars/follow-on-biologics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biosimilars/follow-on-biologics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimilars/follow-on-biologics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biosimilars/follow-on-biologics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimilars/follow-on-biologics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis (Sandoz)
2.1.1 Novartis (Sandoz) Details
2.1.2 Novartis (Sandoz) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis (Sandoz) SWOT Analysis
2.1.4 Novartis (Sandoz) Product and Services
2.1.5 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biogen idec
2.2.1 Biogen idec Details
2.2.2 Biogen idec Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biogen idec SWOT Analysis
2.2.4 Biogen idec Product and Services
2.2.5 Biogen idec Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.3 LG Life Sciences
2.3.1 LG Life Sciences Details
2.3.2 LG Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 LG Life Sciences SWOT Analysis
2.3.4 LG Life Sciences Product and Services
2.3.5 LG Life Sciences Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Synthon Pharmaceuticals
2.4.1 Synthon Pharmaceuticals Details
2.4.2 Synthon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Synthon Pharmaceuticals SWOT Analysis
2.4.4 Synthon Pharmaceuticals Product and Services
2.4.5 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck Serono (Merck)
2.5.1 Merck Serono (Merck) Details
2.5.2 Merck Serono (Merck) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck Serono (Merck) SWOT Analysis
2.5.4 Merck Serono (Merck) Product and Services
2.5.5 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pharmaceutical Industries
2.6.1 Teva Pharmaceutical Industries Details
2.6.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pharmaceutical Industries SWOT Analysis
2.6.4 Teva Pharmaceutical Industries Product and Services
2.6.5 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hospira
2.7.1 Hospira Details
2.7.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hospira SWOT Analysis
2.7.4 Hospira Product and Services
2.7.5 Hospira Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Celltrion Biocon
2.8.1 Celltrion Biocon Details
2.8.2 Celltrion Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Celltrion Biocon SWOT Analysis
2.8.4 Celltrion Biocon Product and Services
2.8.5 Celltrion Biocon Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genentech (Roche)
2.9.1 Genentech (Roche) Details
2.9.2 Genentech (Roche) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Genentech (Roche) SWOT Analysis
2.9.4 Genentech (Roche) Product and Services
2.9.5 Genentech (Roche) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biosimilars/follow-on-biologics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biosimilars/follow-on-biologics Players Market Share
3.2.2 Top 10 Biosimilars/follow-on-biologics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biosimilars/follow-on-biologics Revenue and Market Share by Regions
4.2 North America Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
4.3 Europe Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
4.5 South America Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
5 North America Biosimilars/follow-on-biologics Revenue by Countries
5.1 North America Biosimilars/follow-on-biologics Revenue by Countries (2015-2020)
5.2 USA Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
5.3 Canada Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
5.4 Mexico Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
6 Europe Biosimilars/follow-on-biologics Revenue by Countries
6.1 Europe Biosimilars/follow-on-biologics Revenue by Countries (2015-2020)
6.2 Germany Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
6.3 UK Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
6.4 France Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
6.5 Russia Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
6.6 Italy Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Countries
7.1 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Countries (2015-2020)
7.2 China Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
7.3 Japan Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
7.4 Korea Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
7.5 India Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
8 South America Biosimilars/follow-on-biologics Revenue by Countries
8.1 South America Biosimilars/follow-on-biologics Revenue by Countries (2015-2020)
8.2 Brazil Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
8.3 Argentina Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biosimilars/follow-on-biologics by Countries
9.1 Middle East & Africa Biosimilars/follow-on-biologics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
9.3 UAE Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
9.4 Egypt Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
9.5 South Africa Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biosimilars/follow-on-biologics Revenue and Market Share by Type (2015-2020)
10.2 Global Biosimilars/follow-on-biologics Market Forecast by Type (2019-2024)
10.3 Human growth hormone Revenue Growth Rate (2015-2025)
10.4 Erythropoietin Revenue Growth Rate (2015-2025)
10.5 Monoclonal antibodies Revenue Growth Rate (2015-2025)
10.6 Insulin Revenue Growth Rate (2015-2025)
10.7 Interferon Revenue Growth Rate (2015-2025)
10.8 Granulocyte-Colony Stimulating Factor Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Biosimilars/follow-on-biologics Market Segment by Application
11.1 Global Biosimilars/follow-on-biologics Revenue Market Share by Application (2015-2020)
11.2 Biosimilars/follow-on-biologics Market Forecast by Application (2019-2024)
11.3 Blood disorders Revenue Growth (2015-2020)
11.4 Oncology diseases Revenue Growth (2015-2020)
11.5 Chronic and autoimmune diseases Revenue Growth (2015-2020)
11.6 Growth hormone deficiencies Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Biosimilars/follow-on-biologics Market Size Forecast (2021-2025)
12.1 Global Biosimilars/follow-on-biologics Market Size Forecast (2021-2025)
12.2 Global Biosimilars/follow-on-biologics Market Forecast by Regions (2021-2025)
12.3 North America Biosimilars/follow-on-biologics Revenue Market Forecast (2021-2025)
12.4 Europe Biosimilars/follow-on-biologics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biosimilars/follow-on-biologics Revenue Market Forecast (2021-2025)
12.6 South America Biosimilars/follow-on-biologics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biosimilars/follow-on-biologics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biosimilars/follow-on-biologics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biosimilars/follow-on-biologics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis (Sandoz) Corporate Information, Location and Competitors
Table 6. Novartis (Sandoz) Biosimilars/follow-on-biologics Major Business
Table 7. Novartis (Sandoz) Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 8. Novartis (Sandoz) SWOT Analysis
Table 9. Novartis (Sandoz) Biosimilars/follow-on-biologics Product and Solutions
Table 10. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Biogen idec Corporate Information, Location and Competitors
Table 12. Biogen idec Biosimilars/follow-on-biologics Major Business
Table 13. Biogen idec Biosimilars/follow-on-biologics Total Revenue (USD Million) (2018-2019)
Table 14. Biogen idec SWOT Analysis
Table 15. Biogen idec Biosimilars/follow-on-biologics Product and Solutions
Table 16. Biogen idec Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. LG Life Sciences Corporate Information, Location and Competitors
Table 18. LG Life Sciences Biosimilars/follow-on-biologics Major Business
Table 19. LG Life Sciences Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 20. LG Life Sciences SWOT Analysis
Table 21. LG Life Sciences Biosimilars/follow-on-biologics Product and Solutions
Table 22. LG Life Sciences Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Synthon Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Major Business
Table 25. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 26. Synthon Pharmaceuticals SWOT Analysis
Table 27. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product and Solutions
Table 28. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Serono (Merck) Corporate Information, Location and Competitors
Table 30. Merck Serono (Merck) Biosimilars/follow-on-biologics Major Business
Table 31. Merck Serono (Merck) Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 32. Merck Serono (Merck) SWOT Analysis
Table 33. Merck Serono (Merck) Biosimilars/follow-on-biologics Product and Solutions
Table 34. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Teva Pharmaceutical Industries Corporate Information, Location and Competitors
Table 36. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Major Business
Table 37. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 38. Teva Pharmaceutical Industries SWOT Analysis
Table 39. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product and Solutions
Table 40. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Hospira Corporate Information, Location and Competitors
Table 42. Hospira Biosimilars/follow-on-biologics Major Business
Table 43. Hospira Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 44. Hospira SWOT Analysis
Table 45. Hospira Biosimilars/follow-on-biologics Product and Solutions
Table 46. Hospira Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Celltrion Biocon Corporate Information, Location and Competitors
Table 48. Celltrion Biocon Biosimilars/follow-on-biologics Major Business
Table 49. Celltrion Biocon Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 50. Celltrion Biocon SWOT Analysis
Table 51. Celltrion Biocon Biosimilars/follow-on-biologics Product and Solutions
Table 52. Celltrion Biocon Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Genentech (Roche) Corporate Information, Location and Competitors
Table 54. Genentech (Roche) Biosimilars/follow-on-biologics Major Business
Table 55. Genentech (Roche) Biosimilars/follow-on-biologics Total Revenue (USD Million) (2017-2018)
Table 56. Genentech (Roche) SWOT Analysis
Table 57. Genentech (Roche) Biosimilars/follow-on-biologics Product and Solutions
Table 58. Genentech (Roche) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Biosimilars/follow-on-biologics Revenue (Million USD) by Players (2015-2020)
Table 60. Global Biosimilars/follow-on-biologics Revenue Share by Players (2015-2020)
Table 61. Global Biosimilars/follow-on-biologics Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Biosimilars/follow-on-biologics Revenue Market Share by Regions (2015-2020)
Table 63. North America Biosimilars/follow-on-biologics Revenue by Countries (2015-2020)
Table 64. North America Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Table 65. Europe Biosimilars/follow-on-biologics Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Biosimilars/follow-on-biologics Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Biosimilars/follow-on-biologics Revenue by Countries (2015-2020)
Table 68. South America Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Biosimilars/follow-on-biologics Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Table 71. Global Biosimilars/follow-on-biologics Revenue (Million USD) by Type (2015-2020)
Table 72. Global Biosimilars/follow-on-biologics Revenue Share by Type (2015-2020)
Table 73. Global Biosimilars/follow-on-biologics Revenue Forecast by Type (2021-2025)
Table 74. Global Biosimilars/follow-on-biologics Revenue by Application (2015-2020)
Table 75. Global Biosimilars/follow-on-biologics Revenue Share by Application (2015-2020)
Table 76. Global Biosimilars/follow-on-biologics Revenue Forecast by Application (2021-2025)
Table 77. Global Biosimilars/follow-on-biologics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biosimilars/follow-on-biologics Picture
Figure 2. Global Biosimilars/follow-on-biologics Revenue Market Share by Type in 2019
Figure 3. Human growth hormone Picture
Figure 4. Erythropoietin Picture
Figure 5. Monoclonal antibodies Picture
Figure 6. Insulin Picture
Figure 7. Interferon Picture
Figure 8. Granulocyte-Colony Stimulating Factor Picture
Figure 9. Others Picture
Figure 10. Biosimilars/follow-on-biologics Revenue Market Share by Application in 2019
Figure 11. Blood disorders Picture
Figure 12. Oncology diseases Picture
Figure 13. Chronic and autoimmune diseases Picture
Figure 14. Growth hormone deficiencies Picture
Figure 15. Others Picture
Figure 16. Global Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Biosimilars/follow-on-biologics Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Biosimilars/follow-on-biologics Revenue Market Share in 2019
Figure 25. Global Top 10 Players Biosimilars/follow-on-biologics Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Biosimilars/follow-on-biologics Revenue Market Share by Regions (2015-2020)
Figure 29. Global Biosimilars/follow-on-biologics Revenue Market Share by Regions in 2018
Figure 30. North America Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 31. Europe Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 33. South America Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 35. North America Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Figure 36. North America Biosimilars/follow-on-biologics Revenue Market Share by Countries in 2019
Figure 37. USA Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 38. Canada Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 40. Europe Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Biosimilars/follow-on-biologics Revenue Market Share by Countries in 2019
Figure 42. Germany Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 43. UK Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 44. France Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 45. Russia Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 46. Italy Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Biosimilars/follow-on-biologics Revenue Market Share by Countries in 2019
Figure 49. China Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 50. Japan Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 51. Korea Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 52. India Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 54. South America Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Figure 55. South America Biosimilars/follow-on-biologics Revenue Market Share by Countries in 2019
Figure 56. Brazil Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Biosimilars/follow-on-biologics Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Biosimilars/follow-on-biologics Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 61. UAE Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Biosimilars/follow-on-biologics Revenue and Growth Rate (2015-2020)
Figure 64. Global Biosimilars/follow-on-biologics Revenue Share by Type (2015-2020)
Figure 65. Global Biosimilars/follow-on-biologics Revenue Share by Type in 2019
Figure 66. Global Biosimilars/follow-on-biologics Market Share Forecast by Type (2021-2025)
Figure 67. Global Human growth hormone Revenue Growth Rate (2015-2020)
Figure 68. Global Erythropoietin Revenue Growth Rate (2015-2020)
Figure 69. Global Monoclonal antibodies Revenue Growth Rate (2015-2020)
Figure 70. Global Insulin Revenue Growth Rate (2015-2020)
Figure 71. Global Interferon Revenue Growth Rate (2015-2020)
Figure 72. Global Granulocyte-Colony Stimulating Factor Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Biosimilars/follow-on-biologics Revenue Share by Application (2015-2020)
Figure 75. Global Biosimilars/follow-on-biologics Revenue Share by Application in 2019
Figure 76. Global Biosimilars/follow-on-biologics Market Share Forecast by Application (2021-2025)
Figure 77. Global Blood disorders Revenue Growth Rate (2015-2020)
Figure 78. Global Oncology diseases Revenue Growth Rate (2015-2020)
Figure 79. Global Chronic and autoimmune diseases Revenue Growth Rate (2015-2020)
Figure 80. Global Growth hormone deficiencies Revenue Growth Rate (2015-2020)
Figure 81. Global Others Revenue Growth Rate (2015-2020)
Figure 82. Global Biosimilars/follow-on-biologics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Biosimilars/follow-on-biologics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Biosimilars/follow-on-biologics Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Biosimilars/follow-on-biologics Revenue Market Forecast (2021-2025)
Figure 86. Europe Biosimilars/follow-on-biologics Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Biosimilars/follow-on-biologics Revenue Market Forecast (2021-2025)
Figure 88. South America Biosimilars/follow-on-biologics Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Biosimilars/follow-on-biologics Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
創傷生物製剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Wound Biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wound Biologics market report…- モノクローナル抗体の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Monoclonal Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Monoclonal Antibodies m…
- 生物学的安全性試験の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Biologics Safety Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.7% in the forecast period of 2020 to 2025 and will expected to reach USD 3287.6 million by 2025, from USD 2538.9 million in 2019. The Biologics S…
- 狂犬病モノクローナル抗体の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rabies Monoclonal Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- ヒト羊膜（AM）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Human Amniotic Membrane (AM) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…